Passage BIO, Inc. — Director's Dealing 2022

Oct 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2022-10-10

Reporting Person: Chou William (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-10	Employee Stock Option (right to buy)	$1.32	A	885000	Acquired	2032-10-09	Common Stock (885000)	Direct

Footnotes

F1: The stock option vests as to 25% of the total shares on October 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.